Characterization of the p53-dependent postmitotic checkpoint following spindle disruption

Molecular and Cellular Biology

Volumn 18, Issue 2, 1998, Pages 1055-1064

  Lanni, Jennifer S ^a   Jacks, Tyler ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CYCLE G1 PHASE; CYTOKINESIS; DNA CONTENT; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; FIBROBLAST; GENE DISRUPTION; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPINDLE CELL; TUMOR SUPPRESSOR GENE;

EID: 0031931414     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.2.1055     Document Type: Article

References (42)

1. Brown, C. R., S. J. Doxsey, E. White, and W. J. Welch. 1994. Both viral (adenovirus E1B) and cellular (hsp70, p53) components interact with centrosomes. J. Cell. Physiol. 160:47-60.
2. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
3. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
4. Chen, P. L., P. Scully, J. Y. Shew, J. Y. Wang, and W. H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
5. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
6. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
7. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
8. Di Leonardo, A., S. H. Khan, S. P. Linke, V. Greco, G. Seidita, and G. M. Wahl. 1997. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRB function. Cancer Res. 57:1013-1019.
9. Dunphy, W. G., L. Brizuela, D. Beach, and J. Newport. 1988. The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell 54:423-431.
10. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
11. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
12. Farmer, G., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Prives. 1992. Wild-type p53 activates transcription in vitro. Nature 358:83-86.
13. Fukasawa, K., T. Choi, R. Kuriyama, S. Rulong, and G. F. Vande Woude. 1996. Abnormal centrosome amplification in the absence of p53, Science 271:1744-1747.
14. Gu, Y., C. W. Turck, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
15. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
16. Hermeking, H., and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53, Science 265:2091-2093.
17. Hoyt, M. A., L. Totis, and B. T. Roberts. 1991. S. cerevisiac genes required for cell cycle arrest in response to loss of microtubule function. Cell 66:507-517.
18. Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1-7.
19. Jordan, M. A., D. Thrower, and L. Wilson. 1992. Effects of vinblastine, podophyllotoxin, and nocodazole on mitotic spindles. J. Cell Sci. 102:401-416.
20. Kastan, M., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
21. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
22. Kern, S. E., J. A. Pietenpol, S. Thiagalingam, A. Seymour, K. W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830.
23. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491-7495.
24. Kung, A. L., S. W. Sherwood, and R. T. Schimke. 1990. Cell-line specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. USA 87:9553-9557.
25. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
26. Lew, D. J., V. Dulic, and S. I. Reed. 1991. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66:1197-1206.
27. Li, R., and A. W. Murray. 1991. Feedback control of mitosis in budding yeast. Cell 66:519-531.
28. Li, Y., and R. Benezra. 1996. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274:246-248.
29. Lu, X., S. A. Burbidge, S. Griffin, and H. M. Smith. 1996. Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation. Oncogene 13:413-418.
30. Ludlow, J. W., C. L. Glendening, D. M. Livingston, and J. A. DeCaprio. 1993. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13:367-372.
31. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independcnt pathway. Cancer Res. 54:3391-3395.
32. Mihara, K., X. R. Cao, A. Yen, S. Chandler, B. Driscoll, A. L. Murphree, A. T'Ang, and Y. K. Fung. 1989. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:1300-1303.
33. L and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by initolic spindle damage. Genes Dev. 10:2621-2631.
34. Paulovich, A. G., D. P. Toczyski, and L. H. Hartwell. 1997. When checkpoints fail. Cell 88:315-321.
35. Rieder, C. L., and R. E. Palazzo. 1992. Colcemid and the mitotic cycle. J. Cell Sci. 102:387-392.
36. Rittling, S. R., and D. T. Denhardt. 1992. p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells. Oncogene 7:935-942.
37. Rudner, A. D., and A. W. Murray. 1996. The spindle assembly checkpoint. Curr. Opin. Cell Biol. 8:773-780.
38. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
39. Taylor, S. S., and F. McKeon. 1997. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89:727-735.
40. Tishler, R., S. Calderwood, C. Coleman, and B. Price. 1993. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53:2212-2216.
41. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor ot cyclin kinases. Nature 366:701-704.
42. Zambetti, G. P., J. Bargonneti, K. Walker, C. Prives, and A. J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence clement. Genes Dcv. 6:1143-1152.